Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position

Full repayment eliminates the Company's unsecured revolving credit facility and simplifies its remaining obligationsWinter ...

At 30, I never imagined I would get a 'blood disease'.

At the time, I never imagined I would get a 'blood disease'.Until then, I had been working normally, living with my family, ...
oncodaily

Huyong Zheng at LeukO 2026: Two Decades of Progress, a New Future for Pediatric AML

Two Decades of Progress, a New Future for Pediatric AML / Acute Lymphoblastic Leukemia, Acute promyelocytic Leukemia, ALL, ...
BIOENGINEER

Five Weeks on a Artificial Lung: Child with Leukemia Survives Severe Respiratory Failure

A five-year-old boy with low-risk acute lymphoblastic leukemia survived 34 days of venovenous ECMO for severe pediatric ...
Daily Mail

Inside Selma Blair's extraordinary battle with MS: Years of missed symptoms, other highly unusual conditions and the mystery medication blamed for her midair meltdown

Actress Selma Blair, who shocked fans when she was involved in a midair 'confrontation' over the weekend, has been open about her experience with the neurological disease multiple sclerosis.

Selma Blair pleads not guilty to assault after Delta flight arrest

The actor was arraigned in Queens on two counts of second-degree assault, while a separate federal case over what allegedly ...
FT Markets

Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026

INTerpath-001 data to be presented in Presidential Symposium, featuring the first Phase 3 results for investigational intismeran autogene plus KEYTRUDA ® (pembrolizumab), demonstrating improvements in ...